Login

Punit Dhillon, President & CEO of OncoSec Medical 00:00:00

Share On Facebook Share On Twitter

OncoSec Medical - Biotech Company Developing Treatments for Advanced-stage Skin Cancer

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Weekly Economic Update: Strong Market Performance Despite Modest Data
00:10:00
Frontier Lithium: Advancing North America's Largest Lithium Resource for EV Battery Market
00:10:00
Q1 2023 Market Recap with Jason Gunkel | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
Dave Layton on Shaping a Successful Career in the Industry | Dave Layton, CEO, Partners Group.
00:10:00
The GO Foundation South Australia launches on Friday, February 15, at the Adelaide Fringe Festival along the Torrens River.
00:10:00
Northern Superior Resources: Insights on Ontario and Quebec Gold Projects with CEO Thomas Morris at Swiss Mining Institute 2014
00:10:00
Galan Lithium Limited: Strategic Projects and Future Outlook at the One-to-One Mining Investment Conference in London
00:10:00
"Navigating Market Volatility: Insights from Fidelity International CEO Anne Richards at Davos"
00:10:00
Dr. Kevin Heather on Altar's Expanding Potential and Exploration Strategies
00:10:00
First Philippine Holdings Corporation (FPH) is a diverse Filipino conglomerate committed to enhancing lives and shaping a sustainable future through its varied business interests.
00:10:00
Interview with Stefano Achermann | Stefano Achermann, CEO, Be Think Solve Execute Sp ABET:MIL
00:10:00
Uncovering Promising Investments: Royce Investment Partners' Approach to Identifying Attractive Stocks for the Opportunistic Value Strategy

© 2017 - Neuhu+